Sola B - Search Results

1

Cyclin K and cyclin D1b are oncogenic in myeloma cells.

Marsaud V, Tchakarska G, Andrieux G, Liu JM, Dembele D, Jost B, Wdzieczak-Bakala J, Renoir JM, Sola B. Marsaud V, et al. Among authors: sola b. Mol Cancer. 2010 May 10;9:103. doi: 10.1186/1476-4598-9-103. Mol Cancer. 2010. PMID: 20459741 Free PMC article.

2

Transcriptional and post-transcriptional mechanisms induce cyclin-D1 over-expression in B-chronic lymphoproliferative disorders.

Sola B, Salaün V, Ballet JJ, Troussard X. Sola B, et al. Int J Cancer. 1999 Oct 8;83(2):230-4. doi: 10.1002/(sici)1097-0215(19991008)83:2<230::aid-ijc14>3.0.co;2-j. Int J Cancer. 1999. PMID: 10471532

3

Cyclin D1 expression in patients with multiple myeloma.

Troussard X, Avet-Loiseau H, Macro M, Mellerin MP, Malet M, Roussel M, Sola B. Troussard X, et al. Among authors: sola b. Hematol J. 2000;1(3):181-5. doi: 10.1038/sj.thj.6200025. Hematol J. 2000. PMID: 11920187

4

The selective estrogen receptor modulator 4-hydroxy tamoxifen induces G1 arrest and apoptosis of multiple myeloma cell lines.

Gauduchon J, Gouilleux F, Maillard S, Marsaud V, Renoir MJ, Sola B. Gauduchon J, et al. Among authors: sola b. Ann N Y Acad Sci. 2003 Dec;1010:321-5. doi: 10.1196/annals.1299.057. Ann N Y Acad Sci. 2003. PMID: 15033743

5

The enigmatic role of cyclin D1 in multiple myeloma.

Lesage D, Troussard X, Sola B. Lesage D, et al. Among authors: sola b. Int J Cancer. 2005 Jun 10;115(2):171-6. doi: 10.1002/ijc.20907. Int J Cancer. 2005. PMID: 15688395 Review. No abstract available.

6

4-Hydroxytamoxifen inhibits proliferation of multiple myeloma cells in vitro through down-regulation of c-Myc, up-regulation of p27Kip1, and modulation of Bcl-2 family members.

Gauduchon J, Gouilleux F, Maillard S, Marsaud V, Renoir JM, Sola B. Gauduchon J, et al. Among authors: sola b. Clin Cancer Res. 2005 Mar 15;11(6):2345-54. doi: 10.1158/1078-0432.CCR-04-1668. Clin Cancer Res. 2005. PMID: 15788686

7

Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma.

Maillard S, Ameller T, Gauduchon J, Gougelet A, Gouilleux F, Legrand P, Marsaud V, Fattal E, Sola B, Renoir JM. Maillard S, et al. Among authors: sola b. J Steroid Biochem Mol Biol. 2005 Feb;94(1-3):111-21. doi: 10.1016/j.jsbmb.2004.12.023. Epub 2005 Jan 27. J Steroid Biochem Mol Biol. 2005. PMID: 15862956

8

Cyclin D1 gene activation in human myeloma cells is independent of DNA hypomethylation or histone hyperacetylation.

Krieger S, Grunau C, Sabbah M, Sola B. Krieger S, et al. Among authors: sola b. Exp Hematol. 2005 Jun;33(6):652-9. doi: 10.1016/j.exphem.2005.03.011. Exp Hematol. 2005. PMID: 15911089 Free article.

9

Improved antitumoral properties of pure antiestrogen RU 58668-loaded liposomes in multiple myeloma.

Maillard S, Gauduchon J, Marsaud V, Gouilleux F, Connault E, Opolon P, Fattal E, Sola B, Renoir JM. Maillard S, et al. Among authors: sola b. J Steroid Biochem Mol Biol. 2006 Jul;100(1-3):67-78. doi: 10.1016/j.jsbmb.2006.03.008. Epub 2006 Jun 5. J Steroid Biochem Mol Biol. 2006. PMID: 16753295

10

Antiestrogenic therapies in solid cancers and multiple myeloma.

Sola B, Renoir JM. Sola B, et al. Curr Mol Med. 2006 Jun;6(4):359-68. doi: 10.2174/156652406777435408. Curr Mol Med. 2006. PMID: 16900659 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters